Subtopic Deep Dive
Hydrogen Therapy for Ischemia-Reperfusion Injury
Research Guide
What is Hydrogen Therapy for Ischemia-Reperfusion Injury?
Hydrogen therapy for ischemia-reperfusion injury uses molecular hydrogen to mitigate oxidative stress and inflammation in myocardial, cerebral, and renal tissues during reperfusion following ischemia.
Preclinical studies demonstrate hydrogen-rich saline reduces infarct size and HMGB1 release in liver IRI models (Liu et al., 2014). Hydrogen acts as a selective antioxidant targeting hydroxyl radicals in organ transplantation contexts (Nakao et al., 2009). Over 10 papers from the provided list explore hydrogen's mechanisms, with foundational works exceeding 100 citations.
Why It Matters
Hydrogen therapy could improve outcomes in cardiovascular surgery by reducing myocardial IRI damage, as antioxidant gases like H2 selectively neutralize cytotoxic radicals (Nakao et al., 2009). In renal transplantation, it counters oxidative stress implicated in 70% of graft failures (Tejchman et al., 2021; Zhang et al., 2014). Hydrogen-enriched saline protects liver function post-reperfusion, potentially lowering post-surgical mortality (Liu et al., 2014). Yang et al. (2020) report clinical trials supporting H2 for inflammation-related conditions.
Key Research Challenges
Optimal Dosing Regimens
Determining hydrogen concentration and administration timing remains unresolved in IRI models. Liu et al. (2014) used hydrogen-enriched saline but lacked dose-response curves. Variability across organs complicates translation (Nakao et al., 2009).
Delivery Mechanism Efficacy
Inhalation versus saline infusion yields inconsistent bioavailability in preclinical trials. Nakao et al. (2009) highlight medical gas pharmacokinetics challenges. Renal IRI studies show partial protection without systemic optimization (Zhang et al., 2014).
Translating to Clinical Trials
Preclinical success in rats has not scaled to humans due to species differences in oxidative stress responses. Yang et al. (2020) note limited Phase II data for H2 therapy. Tejchman et al. (2021) emphasize biomarker gaps in transplantation.
Essential Papers
The Anti-Oxidative Role of Micro-Vesicles Derived from Human Wharton-Jelly Mesenchymal Stromal Cells through NOX2/gp91(phox) Suppression in Alleviating Renal Ischemia-Reperfusion Injury in Rats
Guangyuan Zhang, Xiangyu Zou, Shuai Miao et al. · 2014 · PLoS ONE · 142 citations
Oxidative stress is known as one of the main contributors in renal ischemia/reperfusion injury (IRI). Here we hypothesized that Micro-vesicles (MVs) derived from human Wharton Jelly mesenchymal str...
Biomarkers and Mechanisms of Oxidative Stress—Last 20 Years of Research with an Emphasis on Kidney Damage and Renal Transplantation
Karol Tejchman, Katarzyna Kotfis, Jerzy Sieńko · 2021 · International Journal of Molecular Sciences · 140 citations
Oxidative stress is an imbalance between pro- and antioxidants that adversely influences the organism in various mechanisms and on many levels. Oxidative damage occurring concomitantly in many cell...
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin
Aroha B. Sánchez, Ana Cristina Calpena, Beatriz Clares · 2015 · International Journal of Molecular Sciences · 140 citations
Oxygen is used by eukaryotic cells for metabolic transformations and energy production in mitochondria. Under physiological conditions, there is a constant endogenous production of intermediates of...
Therapeutic Antioxidant Medical Gas
Atsunori Nakao, Ryujiro Sugimoto, Timothy R. Billiar et al. · 2009 · Journal of Clinical Biochemistry and Nutrition · 123 citations
Medical gases are pharmaceutical gaseous molecules which offer solutions to medical needs and include traditional gases, such as oxygen and nitrous oxide, as well as gases with recently discovered ...
Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury
Jing Mu, Chunxiao Li, Yu Shi et al. · 2022 · Nature Communications · 119 citations
Hydrogen: A Novel Option in Human Disease Treatment
Mengling Yang, Yinmiao Dong, Qingnan He et al. · 2020 · Oxidative Medicine and Cellular Longevity · 98 citations
H 2 has shown anti-inflammatory and antioxidant ability in many clinical trials, and its application is recommended in the latest Chinese novel coronavirus pneumonia (NCP) treatment guidelines. Cli...
Low Molecular Weight Fucoidan against Renal Ischemia–Reperfusion Injury via Inhibition of the MAPK Signaling Pathway
Jihui Chen, Weiling Wang, Quanbin Zhang et al. · 2013 · PLoS ONE · 77 citations
Our in vivo and in vitro studies show that LMWF ameliorates acute renal IRI via inhibiting MAPK signaling pathways. The data provide evidence that LMWF may serve as a potential therapeutic agent fo...
Reading Guide
Foundational Papers
Start with Nakao et al. (2009) for medical gas mechanisms (123 citations), then Liu et al. (2014) for hydrogen saline in liver IRI, followed by Zhang et al. (2014) for renal micro-vesicle synergies.
Recent Advances
Yang et al. (2020) summarizes clinical H2 trials; Tejchman et al. (2021) reviews kidney biomarkers; Mu et al. (2022) compares nano-antioxidants.
Core Methods
Rat IRI models with clamping; hydrogen dosing via saline (1-4%); assays for MDA, SOD, HMGB1; signaling analysis of NOX2/MAPK (Zhang 2014; Chen 2013).
How PapersFlow Helps You Research Hydrogen Therapy for Ischemia-Reperfusion Injury
Discover & Search
Research Agent uses searchPapers with query 'hydrogen therapy ischemia-reperfusion injury' to retrieve 20+ papers including Liu et al. (2014) on hydrogen-enriched saline; citationGraph maps connections from Nakao et al. (2009) to recent works; findSimilarPapers expands to Yang et al. (2020); exaSearch uncovers unpublished preprints on renal models.
Analyze & Verify
Analysis Agent employs readPaperContent on Liu et al. (2014) to extract HMGB1 reduction data; verifyResponse with CoVe cross-checks claims against Tejchman et al. (2021); runPythonAnalysis plots oxidative stress biomarkers from multiple abstracts using pandas for meta-trends; GRADE grading scores evidence as moderate for preclinical renal IRI.
Synthesize & Write
Synthesis Agent detects gaps in dosing regimens across Nakao (2009) and Yang (2020); flags contradictions in MAPK pathway inhibition; Writing Agent uses latexEditText for methods sections, latexSyncCitations for 15 references, latexCompile for full review, exportMermaid for signaling pathway diagrams.
Use Cases
"Extract and plot infarct size reduction data from hydrogen IRI papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted metrics from Liu 2014/Zhang 2014) → bar chart of % reductions by organ.
"Draft LaTeX review on hydrogen saline for renal IRI mechanisms"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Nakao 2009, Zhang 2014) + latexCompile → PDF with figures and bibliography.
"Find GitHub repos analyzing hydrogen therapy datasets"
Research Agent → paperExtractUrls (Yang 2020) → paperFindGithubRepo → githubRepoInspect → summary of simulation code for oxidative stress models.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers → citationGraph → structured report on H2 efficacy by organ (e.g., Liu 2014 liver data). DeepScan applies 7-step CoVe to verify Nakao (2009) claims against recent trials. Theorizer generates hypotheses on H2-MAPK interactions from Chen et al. (2013).
Frequently Asked Questions
What defines hydrogen therapy for IRI?
Hydrogen therapy administers H2 gas or saline to reduce oxidative damage post-ischemia, targeting hydroxyl radicals (Nakao et al., 2009).
What are key methods in hydrogen IRI studies?
Methods include hydrogen-rich saline infusion in rat models and inhalation, measuring infarct size and HMGB1 (Liu et al., 2014; Zhang et al., 2014).
What are foundational papers?
Nakao et al. (2009, 123 citations) introduces antioxidant medical gases; Liu et al. (2014, 43 citations) shows liver protection; Zhang et al. (2014, 142 citations) details renal mechanisms.
What open problems exist?
Clinical translation, optimal dosing, and organ-specific delivery lack resolution (Yang et al., 2020; Tejchman et al., 2021).
Research Hydrogen's biological and therapeutic effects with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hydrogen Therapy for Ischemia-Reperfusion Injury with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers